Business Of Biotech cover image

Antibody-Cytokine Combinations With Philogen's Dr. Dario Neri

Business Of Biotech

00:00

The Adapto of the Pipeline of Your Company?

Nidlogian fibramen is a dermatoncology product that initially we develop ter in stage three c melanoma. We saw and published what i consider to be strong, fasto clinical data. And we see an opportunity for patients, especially with recurrent stage tre melanoma disease. Once we saw e the efficacy of the product on this superficial melanomalies ons, we thought, ok, why don't we give it also to other skin conditions,. which are nasty and usually received require surgery. Sichas hi risk, basal sel carsinom or, squemo sel Carsinom of the skin. The response rate to standard of care lomostin

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app